These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 20519142)
1. Pamidronate inhibits antiapoptotic bcl-2 expression through inhibition of the mevalonate pathway in prostate cancer PC-3 cells. Iguchi K; Tatsuda Y; Usui S; Hirano K Eur J Pharmacol; 2010 Sep; 641(1):35-40. PubMed ID: 20519142 [TBL] [Abstract][Full Text] [Related]
2. Protein kinase C is inhibited by bisphosphonates in prostate cancer PC-3 cells. Tatsuda Y; Iguchi K; Usui S; Suzui M; Hirano K Eur J Pharmacol; 2010 Feb; 627(1-3):348-53. PubMed ID: 19903468 [TBL] [Abstract][Full Text] [Related]
4. Incadronate inhibits aminopeptidase N expression in prostatic PC-3 cells. Iguchi K; Nakano T; Usui S; Hirano K Cancer Lett; 2006 Jun; 237(2):223-33. PubMed ID: 16019130 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of the mevalonate pathway and activation of p38 MAP kinase are independently regulated by nitrogen-containing bisphosphonates in breast cancer cells. Merrell MA; Wakchoure S; Lehenkari PP; Harris KW; Selander KS Eur J Pharmacol; 2007 Sep; 570(1-3):27-37. PubMed ID: 17640631 [TBL] [Abstract][Full Text] [Related]
6. Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway. Virtanen SS; Väänänen HK; Härkönen PL; Lakkakorpi PT Cancer Res; 2002 May; 62(9):2708-14. PubMed ID: 11980672 [TBL] [Abstract][Full Text] [Related]
7. The effects on hTERT gene expression is an additional mechanism of amino-bisphosphonates in prostatic cancer cells. Valenti MT; Dalle Carbonare L; Bertoldo F; Donatelli L; Lo Cascio V Eur J Pharmacol; 2008 Feb; 580(1-2):36-42. PubMed ID: 18037402 [TBL] [Abstract][Full Text] [Related]
8. Bisphosphonate induces apoptosis and inhibits pro-osteoclastic gene expression in prostate cancer cells. Asahi H; Mizokami A; Miwa S; Keller ET; Koshida K; Namiki M Int J Urol; 2006 May; 13(5):593-600. PubMed ID: 16771731 [TBL] [Abstract][Full Text] [Related]
9. Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells. Goffinet M; Thoulouzan M; Pradines A; Lajoie-Mazenc I; Weinbaum C; Faye JC; Séronie-Vivien S BMC Cancer; 2006 Mar; 6():60. PubMed ID: 16539721 [TBL] [Abstract][Full Text] [Related]
11. Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298. Coxon FP; Helfrich MH; Van't Hof R; Sebti S; Ralston SH; Hamilton A; Rogers MJ J Bone Miner Res; 2000 Aug; 15(8):1467-76. PubMed ID: 10934645 [TBL] [Abstract][Full Text] [Related]
12. The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway. Shipman CM; Croucher PI; Russell RG; Helfrich MH; Rogers MJ Cancer Res; 1998 Dec; 58(23):5294-7. PubMed ID: 9850051 [TBL] [Abstract][Full Text] [Related]
13. Bcl-xL in prostate cancer cells: effects of overexpression and down-regulation on chemosensitivity. Lebedeva I; Rando R; Ojwang J; Cossum P; Stein CA Cancer Res; 2000 Nov; 60(21):6052-60. PubMed ID: 11085527 [TBL] [Abstract][Full Text] [Related]
14. Taxol and estramustine-induced modulation of human prostate cancer cell apoptosis via alteration in bcl-xL and bak expression. Liu QY; Stein CA Clin Cancer Res; 1997 Nov; 3(11):2039-46. PubMed ID: 9815595 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of BCL-X(L) underlies the molecular basis for resistance to staurosporine-induced apoptosis in PC-3 cells. Li X; Marani M; Mannucci R; Kinsey B; Andriani F; Nicoletti I; Denner L; Marcelli M Cancer Res; 2001 Feb; 61(4):1699-706. PubMed ID: 11245486 [TBL] [Abstract][Full Text] [Related]
16. Induction of mitochondria-dependent apoptosis through the inhibition of mevalonate pathway in human breast cancer cells by YM529, a new third generation bisphosphonate. Nakajima H; Magae J; Tsuruga M; Sakaguchi K; Fujiwara I; Mizuta M; Sawai K; Yamagishi H; Mizuta N Cancer Lett; 2007 Aug; 253(1):89-96. PubMed ID: 17316980 [TBL] [Abstract][Full Text] [Related]
17. Zoledronic acid induces apoptosis and inhibits adhesion to mineralized matrix in prostate cancer cells via inhibition of protein prenylation. Coxon JP; Oades GM; Kirby RS; Colston KW BJU Int; 2004 Jul; 94(1):164-70. PubMed ID: 15217454 [TBL] [Abstract][Full Text] [Related]
18. Androgens repress Bcl-2 expression via activation of the retinoblastoma (RB) protein in prostate cancer cells. Huang H; Zegarra-Moro OL; Benson D; Tindall DJ Oncogene; 2004 Mar; 23(12):2161-76. PubMed ID: 14676836 [TBL] [Abstract][Full Text] [Related]
19. Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor beta isoforms 2 and 4. Hayashi K; Goodison S; Urquidi V; Tarin D; Lotan R; Tahara E Int J Oncol; 2003 Mar; 22(3):623-9. PubMed ID: 12579317 [TBL] [Abstract][Full Text] [Related]
20. Magnolol induces apoptosis via inhibiting the EGFR/PI3K/Akt signaling pathway in human prostate cancer cells. Lee DH; Szczepanski MJ; Lee YJ J Cell Biochem; 2009 Apr; 106(6):1113-22. PubMed ID: 19229860 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]